Inventor · disambiguated record
Yonaton Ray
Also filed as: RAY YONATON
6 granted patents·2 pending applications·20 citations·filing 2014–2023
80Inventor score
Files withREGENERON PHARMA8
Top patents by PatentIndex Score
8 records- 0193US9644018B2Antibody modulators of APLNRREGENERON PHARMA·Filed 2015·Granted May 9, 2017·13 cites·11 claims
- 0287US10626173B2Method for treating pathological angiogenesis by administering an antibody that inhibits APLNRREGENERON PHARMA·Filed 2018·Granted Apr 21, 2020·2 cites·20 claims
- 0383US2024091301A1APLNR Modulators and Uses ThereofREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0482US10947310B2Fusion protein comprising apelin and an anti-APLNR antibodyREGENERON PHARMA·Filed 2018·Granted Mar 16, 2021·1 cites·20 claims
- 0582US10189901B2Methods for improving cardiac function by administering an antibody that activates APLNRREGENERON PHARMA·Filed 2017·Granted Jan 29, 2019·2 cites·13 claims
- 0679US10155811B2APLNR modulators and uses thereofREGENERON PHARMA·Filed 2014·Granted Dec 18, 2018·2 cites·20 claims
- 0775US11642390B2Method of treatment with a fusion protein comprising apelin and an anti-APLNR antibodyREGENERON PHARMA·Filed 2021·Granted May 9, 2023·0 cites·18 claims
- 0842US2019002555A1Antigen-binding proteins to marinobufageninREGENERON PHARMA·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yonaton Ray files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →